Home›Companies›Ohalo Genetics

Ohalo Genetics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 25, 2024·Suggest an edit

About Ohalo Genetics

Ohalo Genetics is a private company based in Aptos, California, incorporated in 2019 in Delaware. It has reported $39,999,969 raised in one offering on Form D since January 2024. Its chief executive is David Friedberg.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 10, 2024Jan 25, 2024$39,999,969of $57.0M target8$4.9MEquityRule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ohalo Genetics's Form D filed Jan 25, 2024.

DF
David Friedberg
CEO and director

Sources

  1. SECOhalo Genetics, Inc. filing history